Comments on: Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026) https://cryptoinsider.asia/mineralys-therapeutics-presents-new-data-from-the-phase-3-launch-htn-trial-of-lorundrostat-in-participants-with-hypertension-and-chronic-kidney-disease-at-european-meeting-on-hypertension-and-cardiov/ Crypto and Blockchain News Sat, 30 May 2026 16:12:50 +0000 hourly 1 https://wordpress.org/?v=7.0